BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21323852)

  • 1. New treatment approach for osteopenia.
    Tufts G
    J Midwifery Womens Health; 2011; 56(1):61-67. PubMed ID: 21323852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.
    Chao AS; Chen FP; Lin YC; Huang TS; Fan CM; Yu YW
    Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice.
    Watts NB
    J Womens Health (Larchmt); 2011 Apr; 20(4):525-31. PubMed ID: 21438699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study.
    Esmaeilzadeh S; Cesme F; Oral A; Yaliman A; Sindel D
    Endocr Res; 2016 Aug; 41(3):248-60. PubMed ID: 26864472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelines.
    Bolland MJ; Grey A
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1856-60. PubMed ID: 20147581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus.
    Lee JJ; Aghdassi E; Cheung AM; Morrison S; Cymet A; Peeva V; Neville C; Hewitt S; DaCosta D; Pineau C; Pope J; Fortin PR
    J Rheumatol; 2012 Jul; 39(7):1378-84. PubMed ID: 22660811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recommendations of FRAX in clinical assessment of osteoporosis indicated in European and US guidelines].
    Nakamura T
    Clin Calcium; 2009 Dec; 19(12):1723-8. PubMed ID: 19949262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist.
    Watts NB; Lewiecki EM; Miller PD; Baim S
    J Clin Densitom; 2008; 11(4):473-7. PubMed ID: 18562228
    [No Abstract]   [Full Text] [Related]  

  • 10. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.
    Dawson-Hughes B; Tosteson AN; Melton LJ; Baim S; Favus MJ; Khosla S; Lindsay RL;
    Osteoporos Int; 2008 Apr; 19(4):449-58. PubMed ID: 18292975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fracture assessment tool risk scores in bone density reports do not change physician prescribing behavior for osteoporosis.
    Izuora KE; Alazraki N; Byrd-Sellers J; Tangpricha V; Nanes MS
    Am J Med Sci; 2011 Jul; 342(1):5-8. PubMed ID: 21412137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of osteopenia in Asian women: a new approach.
    Tufts G
    J Am Acad Nurse Pract; 2011 Aug; 23(8):434-42. PubMed ID: 21790837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fracture burden in relation to low bone mineral density and FRAX(®) probability.
    Leslie WD; Morin S
    J Clin Densitom; 2011; 14(3):279-85. PubMed ID: 21723761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FRAX® counseling for bone health behavior change in women 50 years of age and older.
    Dunniway DL; Camune B; Baldwin K; Crane JK
    J Am Acad Nurse Pract; 2012 Jun; 24(6):382-9. PubMed ID: 22672490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 55-year-old woman with osteopenia.
    Cummings SR
    JAMA; 2006 Dec; 296(21):2601-10. PubMed ID: 17148725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone health management in prostate cancer patients receiving androgen deprivation therapy.
    Dhanapal V; Reeves DJ
    J Oncol Pharm Pract; 2012 Mar; 18(1):84-90. PubMed ID: 21807761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of FRAX and future issues in women's health].
    Hashimoto K; Ishitani K; Ohta H
    Clin Calcium; 2009 Dec; 19(12):1742-8. PubMed ID: 19949265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New guidelines for the prevention and treatment of osteoporosis.
    Lewiecki EM; Watts NB
    South Med J; 2009 Feb; 102(2):175-9. PubMed ID: 19139693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the FRAX model for hip fracture predictions in the population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE).
    Sund R; Honkanen R; Johansson H; Odén A; McCloskey E; Kanis J; Kröger H
    Calcif Tissue Int; 2014 Jul; 95(1):39-45. PubMed ID: 24792689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool.
    Lin J; Yang Y; Fei Q; Zhang X; Ma Z; Wang Q; Li J; Li D; Meng Q; Wang B
    Clin Interv Aging; 2016; 11():461-9. PubMed ID: 27217730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.